Episode

2408: MedPal Hits Record Prescription Volumes & £5m Run-Rate

Podcast
The Vox Markets Podcast
Published
Jun 1, 2026
Duration seconds
347
Processing state
not_requested
Canonical source
https://audioboom.com/posts/8910125
Audio
https://dts.podtrac.com/redirect.mp3/audioboom.com/posts/8910125.mp3?modified=1780304656&sid=5051662&source=rss
JSON
/v1/public/podcasts/the-vox-markets-podcast-3914537/episodes/2408-medpal-hits-record-prescription-volumes-5m-run-rate
Markdown
/podcast/the-vox-markets-podcast-3914537/2408-medpal-hits-record-prescription-volumes-5m-run-rate.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/the-vox-markets-podcast-3914537/episodes/2408-medpal-hits-record-prescription-volumes-5m-run-rate/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/the-vox-markets-podcast-3914537/2408-medpal-hits-record-prescription-volumes-5m-run-rate.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

MedPal AI has reported its strongest month since launch, with more than 42,250 prescription items dispensed in May and cumulative volumes now above 250,000. In this interview, CEO Jason Drummond discusses what is driving the growth, whether 34% pharmacy gross margins are sustainable, and how investors should judge the path from operational momentum to cash generation.